Target intelligence / Profile preview

MicroRNA 548ac (miR-548ac)

Target
miR-548ac
Molecular classification
MicroRNA, Non-coding RNA, Other
01

Overview

MicroRNA 548ac (miR-548ac) is a member of the microRNA family, encoded by the MIR548AC gene located within the first intron of the CD58 gene in humans. As a microRNA, miR-548ac is a non-coding RNA molecule approximately 20-24 nucleotides in length, functioning to regulate gene expression post-transcriptionally by binding to target mRNAs and promoting their degradation or inhibiting their translation. miR-548ac has been implicated in various cellular processes including inflammatory response regulation and cellular stress adaptation. Genetic variants affecting miR-548ac levels, particularly SNPs in its stem-loop region, are associated with altered risk of multiple sclerosis by modifying the expression of both miR-548ac and its host gene CD58 in immune cells. Experimentally, miR-548ac plays roles in modulating the transition of endothelial cells to mesenchymal states, notably under acidic stress by targeting proteins such as YB-1 and Snail, pathways relevant to cancer progression and metastasis. Its dysregulation is seen in certain cancers and neuroinflammatory disorders, making it a potential disease biomarker but not a direct drug target.

Other names
hsa-miR-548acMIR548AChsa-mir-548acmicroRNA-548ac
02

Mechanism of action

Not applicable (endogenous regulator; not a protein drug target)

03

Biological functions

Post-transcriptional gene silencingRegulation of gene expressionInflammatory process regulationProtein folding regulationEndothelial-to-mesenchymal transition (EndMT) modulation
04

Disease associations

CancerMultiple sclerosisPancreatic cancerStomach carcinoma in situOther inflammatory disorders
05

Safety considerations

None specifically reportedchallenges relate to specificity, delivery, and off-target effects in therapeutic modulation of microRNAs in general
06

Interacting drugs

None known (no direct pharmacological modulators or drugs targeting miR-548ac as of current knowledge)
07

Biomarkers

Potential biomarker in multiple sclerosis (MS) risk allelesmay also serve as a functional biomarker in some cancer subtypes or inflammatory conditions

Beyond the preview

Go deeper on MicroRNA 548ac (miR-548ac).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 548ac (miR-548ac).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call